Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Calculi | 8 | 2021 | 34 | 2.220 |
Why?
|
| Kidney Neoplasms | 5 | 2022 | 173 | 1.120 |
Why?
|
| Ureter | 3 | 2023 | 37 | 1.000 |
Why?
|
| Ureteroscopy | 7 | 2021 | 19 | 0.840 |
Why?
|
| Urologic Diseases | 2 | 2021 | 18 | 0.770 |
Why?
|
| Urology | 2 | 2021 | 46 | 0.740 |
Why?
|
| Smartphone | 2 | 2019 | 75 | 0.700 |
Why?
|
| Dilatation | 1 | 2021 | 34 | 0.670 |
Why?
|
| Iatrogenic Disease | 1 | 2021 | 58 | 0.650 |
Why?
|
| Lithotripsy, Laser | 1 | 2020 | 5 | 0.650 |
Why?
|
| Ureteral Calculi | 1 | 2020 | 8 | 0.640 |
Why?
|
| Lithotripsy | 1 | 2020 | 11 | 0.640 |
Why?
|
| Virtual Reality | 1 | 2020 | 16 | 0.640 |
Why?
|
| Mitomycin | 1 | 2018 | 29 | 0.550 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2018 | 38 | 0.550 |
Why?
|
| BCG Vaccine | 1 | 2018 | 57 | 0.540 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2018 | 46 | 0.530 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 109 | 0.500 |
Why?
|
| Adjuvants, Immunologic | 1 | 2018 | 237 | 0.500 |
Why?
|
| Drug Monitoring | 1 | 2018 | 203 | 0.490 |
Why?
|
| Telemedicine | 1 | 2019 | 376 | 0.420 |
Why?
|
| Nephrectomy | 4 | 2022 | 93 | 0.390 |
Why?
|
| Quality of Life | 1 | 2021 | 1265 | 0.390 |
Why?
|
| Laparoscopy | 3 | 2021 | 492 | 0.350 |
Why?
|
| Nephrostomy, Percutaneous | 2 | 2021 | 8 | 0.330 |
Why?
|
| Nephrolithotomy, Percutaneous | 2 | 2021 | 2 | 0.330 |
Why?
|
| Kidney | 3 | 2021 | 458 | 0.310 |
Why?
|
| Biopsy | 3 | 2022 | 460 | 0.230 |
Why?
|
| Humans | 20 | 2022 | 65650 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2021 | 1662 | 0.210 |
Why?
|
| Internship and Residency | 2 | 2022 | 802 | 0.210 |
Why?
|
| Fibroins | 1 | 2023 | 6 | 0.190 |
Why?
|
| Male | 12 | 2021 | 31295 | 0.190 |
Why?
|
| Female | 13 | 2023 | 34309 | 0.190 |
Why?
|
| Recurrence | 2 | 2021 | 664 | 0.180 |
Why?
|
| Retrospective Studies | 5 | 2022 | 6948 | 0.180 |
Why?
|
| Prospective Studies | 4 | 2021 | 3329 | 0.170 |
Why?
|
| Urological Agents | 1 | 2021 | 2 | 0.170 |
Why?
|
| Crowdsourcing | 1 | 2021 | 15 | 0.170 |
Why?
|
| Robotics | 1 | 2022 | 86 | 0.170 |
Why?
|
| Urography | 1 | 2021 | 13 | 0.170 |
Why?
|
| Hypercalciuria | 1 | 2020 | 2 | 0.170 |
Why?
|
| Hematuria | 1 | 2021 | 23 | 0.170 |
Why?
|
| Pyelonephritis, Xanthogranulomatous | 1 | 2020 | 1 | 0.170 |
Why?
|
| Hyperoxaluria | 1 | 2020 | 10 | 0.160 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 113 | 0.160 |
Why?
|
| Middle Aged | 8 | 2021 | 18439 | 0.160 |
Why?
|
| Citric Acid | 1 | 2020 | 20 | 0.160 |
Why?
|
| North America | 1 | 2021 | 114 | 0.160 |
Why?
|
| Uric Acid | 1 | 2020 | 47 | 0.160 |
Why?
|
| Urolithiasis | 1 | 2020 | 5 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 59 | 0.160 |
Why?
|
| Radiation Dosage | 1 | 2021 | 140 | 0.160 |
Why?
|
| Therapeutic Irrigation | 1 | 2019 | 17 | 0.150 |
Why?
|
| Preoperative Care | 1 | 2021 | 199 | 0.150 |
Why?
|
| Endoscopes | 1 | 2019 | 6 | 0.150 |
Why?
|
| Cystoscopy | 1 | 2019 | 17 | 0.150 |
Why?
|
| Lenses | 1 | 2019 | 9 | 0.150 |
Why?
|
| Operating Rooms | 1 | 2019 | 60 | 0.150 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 82 | 0.150 |
Why?
|
| Administration, Intravesical | 1 | 2018 | 14 | 0.140 |
Why?
|
| Contrast Media | 1 | 2021 | 432 | 0.140 |
Why?
|
| Self Report | 1 | 2021 | 394 | 0.140 |
Why?
|
| Aged | 5 | 2021 | 15089 | 0.130 |
Why?
|
| Ureterolithiasis | 1 | 2017 | 14 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 289 | 0.130 |
Why?
|
| Stents | 1 | 2021 | 501 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 133 | 0.120 |
Why?
|
| Swine | 3 | 2023 | 397 | 0.120 |
Why?
|
| Patients | 1 | 2016 | 117 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 807 | 0.100 |
Why?
|
| Adult | 6 | 2021 | 17511 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2020 | 1335 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2730 | 0.100 |
Why?
|
| Image-Guided Biopsy | 2 | 2022 | 50 | 0.090 |
Why?
|
| Physicians | 1 | 2016 | 486 | 0.080 |
Why?
|
| Urologists | 2 | 2022 | 3 | 0.080 |
Why?
|
| Ureteroscopes | 2 | 2020 | 4 | 0.080 |
Why?
|
| Operative Time | 2 | 2019 | 94 | 0.070 |
Why?
|
| Israel | 2 | 2017 | 26 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2022 | 731 | 0.060 |
Why?
|
| Cystectomy | 1 | 2023 | 35 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2023 | 48 | 0.050 |
Why?
|
| Electromyography | 1 | 2022 | 99 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2021 | 67 | 0.040 |
Why?
|
| Peristalsis | 1 | 2021 | 5 | 0.040 |
Why?
|
| Injections | 1 | 2021 | 84 | 0.040 |
Why?
|
| Endoscopy | 1 | 2021 | 92 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 593 | 0.040 |
Why?
|
| Renal Circulation | 1 | 2020 | 14 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 59 | 0.040 |
Why?
|
| Diuresis | 1 | 2020 | 6 | 0.040 |
Why?
|
| California | 1 | 2020 | 178 | 0.040 |
Why?
|
| Kidney Pelvis | 1 | 2020 | 13 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2021 | 138 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 372 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 76 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 317 | 0.040 |
Why?
|
| Cystoscopes | 1 | 2019 | 1 | 0.040 |
Why?
|
| Color | 1 | 2019 | 26 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 130 | 0.040 |
Why?
|
| Laparoscopes | 1 | 2019 | 23 | 0.040 |
Why?
|
| Global Health | 1 | 2020 | 181 | 0.040 |
Why?
|
| Cadaver | 1 | 2019 | 135 | 0.040 |
Why?
|
| Animals | 3 | 2023 | 21467 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 140 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 373 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2019 | 757 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 995 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 931 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1026 | 0.030 |
Why?
|
| Surgeons | 1 | 2019 | 191 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2016 | 33 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 442 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 900 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 170 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2016 | 535 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 828 | 0.020 |
Why?
|
| Anxiety | 1 | 2016 | 427 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 1592 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 3777 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5656 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 5466 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 2113 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 5820 | 0.020 |
Why?
|